KING HUSSEIN CANCER CENTER
🇯🇴Jordan
Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients
Not Applicable
Withdrawn
- Conditions
- COVID-19
- Interventions
- Drug: HCQ & AZ
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- King Hussein Cancer Center
- Registration Number
- NCT04354597
- Locations
- 🇯🇴
King Hussein Cancer Center, Amman, Jordan
Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy
Not Applicable
Completed
- Conditions
- AnemiaCancer
- Interventions
- Drug: Ferric carboxymaltose (FCM)
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- King Hussein Cancer Center
- Target Recruit Count
- 84
- Registration Number
- NCT04246021
Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis
Not Applicable
Terminated
- Conditions
- SepsisSeptic ShockNeoplasmCritical Illness
- Interventions
- Diagnostic Test: Procalcitonin LevelsOther: Control
- First Posted Date
- 2019-12-18
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- King Hussein Cancer Center
- Target Recruit Count
- 157
- Registration Number
- NCT04203524
- Locations
- 🇯🇴
King Hussein Cancer Center, Amman, Jordan
Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients
Phase 2
Withdrawn
- Conditions
- Colorectal Cancer
- Interventions
- Dietary Supplement: Probiotic Formula CapsuleDrug: Control
- First Posted Date
- 2018-11-15
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- King Hussein Cancer Center
- Registration Number
- NCT03742596
- Locations
- 🇯🇴
King Hussein Cancer Center, Amman, Jordan
Is Tunneling Effective in Preventing Failure of Epidural Analgesia? A Randomized Trial
Not Applicable
Completed
- Conditions
- Post Operative PainEpidural Catheter
- Interventions
- Procedure: tunneling epidural catheter
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- King Hussein Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT03706352
Radiation Oncology Mobile Application
Withdrawn
- Conditions
- Radiation ToxicityHead and Neck Cancer
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- King Hussein Cancer Center
- Registration Number
- NCT03707860
- Locations
- 🇯🇴
King Hussein Cancer Center, Amman, Jordan
Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection
Not Applicable
- Conditions
- Breast Cancer
- Interventions
- Device: Glubran 2
- First Posted Date
- 2014-05-19
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- King Hussein Cancer Center
- Target Recruit Count
- 136
- Registration Number
- NCT02141373
- Locations
- 🇯🇴
King Hussein Cancer Center, Amman, Jordan
© Copyright 2025. All Rights Reserved by MedPath